![Raf Roelands](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raf Roelands
Directeur/Membre du Conseil chez
Ontoforce NV
Profil
Raf Roelands is currently Director at Ontoforce NV, Director at MRM Health NV since 2020, Director at Hypervision Surgical Ltd. since 2023, and Partner at Heran Partners BV.
Former positions include Director at reMYND NV and Senior Investment Manager at Korys Management NV from 2021 to 2022.
Education includes graduate degrees from Vlerick Leuven Gent Management School in 2016 and Katholieke Universiteit Leuven in 2009.
Postes actifs de Raf Roelands
| Sociétés | Poste | Début |
|---|---|---|
Ontoforce NV
 Ontoforce NV Packaged SoftwareTechnology Services Creates and implements pioneering technology for information flow and management | Directeur/Membre du Conseil | - |
MRM Health NV
 MRM Health NV BiotechnologyHealth Technology Operates biopharmaceutical company that focuses on the discovery and development of innovative therapeutics based on the human micro biome | Directeur/Membre du Conseil | 01/02/2020 |
Hypervision Surgical Ltd.
 Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Provides AI-powered spectral imaging services of surgeries | Directeur/Membre du Conseil | 01/06/2023 |
Heran Partners BVBA
 Heran Partners BVBA Investment ManagersFinance Heran Partners invests in private companies located in Europe. The firm focuses on the health technology sector. It participates in seed stage, early stage and growth stage transactions with an investment size of EUR 5 - 50 million. The firm acquires minority and majority interests and makes co-investments. | Private Equity Investor | - |
Anciens postes connus de Raf Roelands
| Sociétés | Poste | Fin |
|---|---|---|
Korys Management NV
 Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Analyste en capital-investissement | 01/06/2019 |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Directeur/Membre du Conseil | - |
Formation de Raf Roelands
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Finance |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
 Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
Ontoforce NV
Ontoforce NV Packaged SoftwareTechnology Services Creates and implements pioneering technology for information flow and management | Technology Services |
Heran Partners BVBA
Heran Partners BVBA Investment ManagersFinance Heran Partners invests in private companies located in Europe. The firm focuses on the health technology sector. It participates in seed stage, early stage and growth stage transactions with an investment size of EUR 5 - 50 million. The firm acquires minority and majority interests and makes co-investments. | Finance |
MRM Health NV
MRM Health NV BiotechnologyHealth Technology Operates biopharmaceutical company that focuses on the discovery and development of innovative therapeutics based on the human micro biome | Health Technology |
Hypervision Surgical Ltd.
Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Provides AI-powered spectral imaging services of surgeries | Technology Services |
